Méningoencéphalite d*origine inconnue

Download Report

Transcript Méningoencéphalite d*origine inconnue

Dr. Andrea Finnen
DVM, DES, MSc, DACVIM (Neurology)

Lipid soluble

Protein bound – free portion important

Interact with receptor IN cell

Transcribe genes

or protein

Affect biological action
Effect
Site of action
Gluconeogenesis
 Hepatic glycogen
 Blood glucose
 Lipolysis
 Water excretion
 Gastric acid secretion
Catabolic
−ve feedback CRH
Block inflammatory response
Suppress immune system
Liver
Liver
Liver
Adipose tissue
Kidney
Stomach
Muscle, liver
Hypothalamus
Diffuse
Macro, lymphs

Inhibit synthesis of inflammatory mediators
(prostaglandins, thromboxanes, leukotrienes)
Phospholipids
STEROIDS
Arachidonic Acid
Leukotrienes
Inflammation
Prostaglandins
Physiological Functions
NSAIDS
Prostaglandins
Inflammation




Inhibit synthesis of inflammatory mediators
(prostaglandins, thromboxanes, leukotrienes)
Stabilize lysosomal membranes - rupture
and release of proteolytic enzymes
Attenuates fever by Il-1, reduces
vasodilation
Pain relief via anti-inflammatory actions

permeability of capilliaries

migration WBC into tissues


Suppresses immune system by Tcell
lymphocytes and Tcell antibody production
Prevent fibrin deposition and connective
tissue synthesis






PU/PD
PP, weight gain
Potbelly
Panting
Lethargy
Muscle
atrophy/weakness









Common
Alopecia
Thin skin
Comedones
Bruising
Hyperpigmentation
Calcinosis cutis
Pyoderma
Seborrhea
2° demodex
Dermatologic



Proteinuria
urine glucose
Recurrent UTI






Diabetes mellitus
Euthyroid sick






Renal/endocrine
 TT4, T3, TSH
Hyperglycemia
Hyperlipidemia
Hypercholesterolemia
ALP
Lymphopenia
Neutrophila
Eosinopenia
Hypokalemia
Hyperlactatemia
Blood work
abnormalities





Vomiting
Diarrhea
Gastric ulceration
Colonic perforation
Urinary tract infection *

30x more potent than
cortisol


7x more potent than
Prednisone


2x mineralocorticoid effects


Greater penetration into
CSF


4x more potent than
cortisol
Minimal mineralocorticoid
effects
Prednisolone in cats better
absorbed
Biologic effect 12-36hr
Biologic effect ≤48hr
Dexamethasone
Prednisone
Prednisone
0.5-1mg/kg/day
Prednisone
1-2mg/kg/day DOG
up to 4mg/kg/day CAT
Dexamethasone
0.075-0.15mg/kg/day
Dexamethasone
up to 0.3mg/kg/day
Anti-Inflammatory
Immunosuppressive

Many neurological diseases have an
inflammatory or immune etiology

Sometimes steroids are the only treatment

If you think it’s inflammatory and it’s not…

Think about what you are treating before Rx Diagnosis is key!

Degenerative myelopathy (DM)

FCEM

Coonhound paralysis

Trigeminal neuritis

Ischemic infarct (stroke)

Bengal polyneuropathy

Steroid responsive meningitis-arteritis (SRMA)

Meningoencephalitis of unknown etiology (MUE)

Intracranial neoplasia

IVDD Type I and II

Cervical spondylomyelopathy (Wobblers)

COMS + syringomyelia (SM)

Hydrocephalus

Steroid responsive meningitis-arteritis (SRMA)

Meningoencephalitis of unknown etiology (MUE)

Intracranial neoplasia

IVDD Type I and II

Cervical spondylomyelopathy (Wobblers)

COMS + syringomyelia (SM)

Hydrocephalus

Head trauma

Spinal trauma

Infectious encephalitis/abscess

Lumbosacral disease

Myasthenia Gravis

Signalment + clinical signs
Imaging – MRI preferred for CNS
+/-CSF
+/- biopsy, culture

But……client have only $100 to spend…..





4 yo FS Miniature poodle
Presenting complaint: walking funny
◦
◦
◦
◦
◦

Hind end ataxia (grade 2)
Delayed paw placement both HL
Back pain at TL junction
Appetite decreased
Lethargic, not moving around much
Top 2 differentials:
◦ IVDD
◦ Meningomyelitis
◦ +/- Others (trauma, infectious, neoplasia, FCEM, etc)

Inflammatory
◦
◦
◦
◦

IVDD
Other spinal cord/nerve compression
CSF over-production
Unknown dx
Immune
◦ Definitively diagnosed
◦ Hard to justify high dose steroids if no definitive dx!

“Evaluation of the Success of Medical Management for
Presumptive Thoracolumbar IVDD in Dogs”
Levine, VS 2007

Conclusion:

◦ “…glucocorticoids may negatively impact success and QOL.”

Discussion:
◦ “…possible that glucocorticoids have a negative impact on dogs
with medically managed presumptive disk herniation.”

“Evaluation of the Success of Medical Management for
Presumptive Cervical IVDD in Dogs”
Levine, VS 2007

Conclusions:

Discussion:

◦ “NSAIDs should be considered as part of the therapeutic regimen.”
◦ “…glucocorticoid administration does not appear to benefit these
dogs..”
◦ “…glucocorticoids were less likely to have a successful outcome
but this association was also not statistically significant.”
◦ NSAIDs seem to be associated with success in dogs with
presumptive cervical disk herniation..”

“Recurrence rate of presumed thoracolumbar disc disease
in ambulatory dogs with spinal hyperpathia treated with
anti-inflammatory drugs: 78 cases (1997-2000).”
Mann et al., JVECC 2007

Conclusions:

◦ “Dogs treated with NSAIDs or MPSS were less likely to experience
recurrence than dogs treated with corticosteroids other than MPSS.”

Discussion:
◦ “…impossible to determine whether any of the drugs used are
necessary for recovery of the initial episodes of presumed IVDD…”



“Adverse effects and outcome associated with
dexamethasone administration in dogs with acute
thoracolumbar intervertebral disk herniation: 161 cases
(2000-2006).”
Levine, JAVMA 2008
Conclusions:
◦ “…treatment with dexamethasone before surgery is associated
with more adverse effects, compared with treatment with
glucocorticoids other than dexamethasone or no treatment with
glucocorticoids…”



DOSE 1-30mg/kg!!!!!
3.4x more likely to develop AE
66% non treatment had AE too

CVT XV Chapter 233 Canine IVDH
◦ Medical therapy:
 2-4 weeks cage rest and analgesia with NSAID and opioids
+/- drugs for neuropathic pain
◦ “The use of corticoids such as Dexamethasone is
strongly discouraged for acute SCI from IVDH.”
◦ “..glucocorticoid therapy was negatively associated with
improved functional outcome.” (Levine, 2007)





Inhibit platelet aggregation
Aspirin has irreversible action!
Risk of gastric ulceration and GI effects
Can lead to renal damage
Need 48-72 hour wash-out



Ideally – MRI +
decompressive surgery
Dexamethasone 0.10.15mg/kg/day for 35 days
+/- Prednisone antiinflammatory tapering
for 1 week




No diagnosis?
Dexamethasone 0.1mg/kg/day x 1 week then
0.05mg/kg/day x 1 week
Recheck – better?
STOP or switch to Prednisone for longer
maintenance





Steroids are not all bad!
Think about what you are treating
Use appropriate doses
Follow up and D/C when possible
Don’t use steroids with NSAIDS!